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OBJECTIVES The purpose of this study was to determine the prognostic accuracy of electron beam
computed tomographic (CT) scanning of the coronary arteries and the relationship of
coronary calcification to standard coronary disease risk factors and C-reactive protein (CRP)
in the prediction of atherosclerotic cardiovascular disease (ASCVD) events in apparently
healthy middle-age persons.
BACKGROUND As a screening test for coronary artery disease (CAD), electron beam CT scanning remains
controversial.
METHODS In a prospective, population-based study, 4,903 asymptomatic persons age 50 to 70 years
underwent electron beam CT scanning of the coronary arteries.
RESULTS At 4.3 years, follow-up was available in 4,613 participants (94%), and 119 had sustained at
least one ASCVD event. Subjects with ASCVD events had higher baseline coronary calcium
scores (median [interquartile range], Agatston method) than those without events: 384 (127,
800) versus 10 (0, 86) (p 0.0001). For coronary calcium score threshold100 versus100,
relative risk (95% confidence interval) was 9.6 (6.7 to 13.9) for all ASCVD events, 11.1 (7.3
to 16.7) for all CAD events, and 9.2 (4.9 to 17.3) for non-fatal myocardial infarction and
death. The coronary calcium score predicted CAD events independently of standard risk
factors and CRP (p  0.004), was superior to the Framingham risk index in the prediction
of events (area under the receiver-operating characteristic curve of 0.79  0.03 vs. 0.69 
0.03, p  0.0006), and enhanced stratification of those falling into the Framingham
categories of low, intermediate, and high risk (p  0.0001).
CONCLUSIONS The electron beam CT coronary calcium score predicts CAD events independent of standard
risk factors, more accurately than standard risk factors and CRP, and refines Framingham risk
stratification. (J Am Coll Cardiol 2005;46:158–65) © 2005 by the American College of


















fost coronary artery disease (CAD) events occur on a
ubstrate of moderate to severe atherosclerosis (1–4). This
act, together with recognition of the limitations of conven-
ional risk fa ctor assessment and improvements in technol-
See page 173
gy, has generated increasing interest in noninvasive mea-
ures of atherosclerosis. These include carotid intima-media
hickness (5), ankle-brachial index (6), and fast computed
omographic (CT) scanning of the coronary arteries.
Coronary calcification occurs in rough proportion to the
everity of underlying atherosclerosis (7,8) and can be
easured with a high degree of accuracy and reproducibility
ith electron beam CT (9,10). However, the use of electron
eam CT scanning as a screening test for CAD has been
nd remains controversial (11,12). The strongest supporting
vidence has come from retrospective analyses of commer-
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orted by a grant from the St. Francis Hospital Foundation. Dr. Goodman owns
hares of General Electric, which purchased Imatron approximately three years ago.w
Manuscript received December 28, 2004; revised manuscript received February 17,
005, accepted February 22, 2005.ial scanning databases (13–16), which are subject to referral
ias, and the only prospective study has yielded conflicting
esults (17–19). Therefore, we sought to determine the
rognostic accuracy of electron beam CT scanning of the
oronary arteries and the relationship of coronary calcifica-
ion to standard CAD risk factors and C-reactive protein
CRP) in the prediction of atherosclerotic cardiovascular
isease (ASCVD) events in apparently healthy adults.
ETHODS
eneral study design has been described in detail elsewhere
20) and is diagrammed in Figure 1.
The primary purpose of the St. Francis Heart Study was
o compare the prognostic accuracy of electron beam CT
canning of the coronary arteries with that of standard and
utative CAD risk factors in a setting of primary preven-
ion. Accordingly, men and women age 50 to 70 years were
onsidered eligible provided they had no history, symptoms
Rose questionnaire [21]), or signs of ASCVD.
Other exclusion criteria included indications for risk
actor modification or conditions that might interfere
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July 5, 2005:158–65 Coronary Calcium and ASCVD Eventstudy. The former consisted of insulin-dependent diabe-
es, triglycerides 500 mg/dl, and in men, low-density
ipoprotein (LDL) cholesterol 175 mg/dl (22). The
pper limit for cholesterol in women, total cholesterol
300 mg/dl, was chosen in the absence of any proof
circa January 1996) of benefit of cholesterol-lowering
herapy in a setting of primary prevention in women and
o conform to local practice patterns.
Electron beam CT scanning was performed at the time of
nrollment with an Imatron C-150 XP scanner (Imatron,
outh San Francisco, California) with a reconstruction field
Abbreviations and Acronyms
ASCVD  atherosclerotic cardiovascular disease
CAD  coronary artery disease
CI  confidence interval
CRP  C-reactive protein
CT  computed tomography/tomographic
HDL  high-density lipoprotein
LDL  low-density lipoprotein
MI  myocardial infarction
ROC  receiver-operating characteristicigure 1. Flow diagram of the St. Francis Heart Study. Follow-up was availabl
ligible subjects in whom risk factors were measured. CRP  C-reactive proteif view of 26 cm. Forty contiguous 3-mm slices were
canned during a single breath hold, beginning at the carina.
can time was 100 ms/slice, synchronized to 80% of the RR
nterval. At least two adjacent pixels with an attenuation
oefficient 130 Hounsfield units defined a calcified lesion,
nd coronary calcium scores were calculated using the
ethod of Agatston et al. (23).
Subjects with coronary calcium scores above the 80th
ercentile for age and gender, as defined by an internal
atabase comprising more than 5,000 asymptomatic per-
ons, were invited to participate in a double-blind,
lacebo-controlled, randomized clinical trial of atorvasta-
in and antioxidant vitamins (Figure 1). In order to avoid
he confounding effect of treatment, subjects assigned to
he active treatment arm of the randomized clinical trial
ere excluded from this, the natural history component
f the St. Francis Heart Study. In addition, at the
nsistence of the St. Francis Hospital Institutional Re-
iew Board, which approved this study, all subjects with
alcium scores 80th percentile were given 81 mg of
spirin daily. Thus, the control arm of the randomized
linical trial represents the extension of the naturale at 4.3 years on 4,613 of the 4,903 (94%) and 1,293 of the 1,357 (95%)
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Coronary Calcium and ASCVD Events July 5, 2005:158–65istory study into the realm of high calcium scores but
as perturbed by treatment with aspirin.
Whereas medical histories and the Rose questionnaire
ere obtained on all subjects, physical examinations, elec-
rocardiograms, lipid levels, CRP, and other blood tests
ere obtained only on randomized clinical trial participants
nd, initially, one in five low-score subjects, later one in six
ow-score subjects, selected at random. C-reactive protein
as measured by latex immunonephelometry on a BN
rospec analyzer (Dade Behring, Newark, Delaware [24])
sing Dade Behring reagents by a technician blinded to all
ther patient information. All randomized clinical trial
articipants and the low-score subjects in whom risk factors
ere measured also underwent repeat electron beam CT
cans at two and four years after enrollment.
This study was approved by the St. Francis Hospital
nstitutional Review Board. All participants gave informed
onsent.
The primary hypothesis tested by the natural history
tudy was that the coronary calcium score would add
ncremental prognostic value to standard CAD risk factors.
nd points of interest, verified by an independent commit-
ee of current or former coronary care unit directors at
cademic medical centers, blinded to the coronary calcium
core, included coronary death, nonfatal myocardial infarc-
ion (MI), surgical or percutaneous coronary revasculariza-
ion procedures, non-hemorrhagic stroke, and peripheral
ascular (i.e., arterial) surgery. In cases in which a study
articipant experienced more than one end point, only the
rst end point was counted.
tatistical analysis. Areas under receiver-operating char-
cteristic (ROC) curves and their standard errors were
alculated using the method of Hanley and McNeil (25).
he statistical significance of differences in areas under
OC curves for the same patients, but for different tests
i.e., calcium score versus standard risk factors), were also
alculated using the method of Hanley and McNeil (26),
hich adjusts for the correlation of the two areas due to the
act that the same patients are used for both ROC curves.
he distributions of coronary calcium scores were highly
kewed and were compared using Wilcoxon rank sum tests.
orrelations of calcium scores with continuous variables
ere calculated using Spearman correlations. Associations
f risk factors and dichotomized calcium scores with events
ere assessed in univariate analyses from the aforemen-
ioned descriptors of test performance as well as relative
isks. Relative risks were calculated as the proportion of
ndividuals experiencing an event in the exposed versus
nexposed groups. The significance of relative risks were
ssessed by calculating their standard error using the first-
rder Taylor series approximation for the variance of the
og-relative risk and determining if they were different from
ne. For assessing the significance of trends in proportions
f individuals experiencing events over a variable with three
rdinal categories, a Cochran-Mantel-Haenszel test for
inear trend of proportions was used. Multiple logistic tegression was used to determine if multiple risk factors
ith and without calcium score predicted events while
imultaneously adjusting for all variables in the model
27–29). The statistical significance of risk factors and the
alcium score was assessed by likelihood ratio tests, which
nabled determination of incremental improvement in pre-
iction of events after all other variables were considered.
ultiple ordinary least-squares regression on log (calcium
core 1) was used to assess the independent association of
ultiple risk factors with the coronary calcium score.
ignificant colinearity was ruled out by calculating variance
nflation factors for each independent variable. Multiple
ogistic regression analyses were performed with and with-
ut CRP levels10 mg/l. Unless otherwise noted, results of
nalyses including all CRP values are presented.
With the exception of non-parametric analyses, and
nless otherwise specified, observations in all analyses were
eighted by the inverse probability of an individual being
ncluded in the sample. Thus, for example, in the calculation
f baseline characteristics, subjects with scores above the
0th percentile for age and gender assigned to the control
rm of the randomized clinical trial were counted twice
elative to subjects with scores at or below the 80th
ercentile, since high-score subjects assigned to the active
reatment arm were excluded from further analysis. All
eights were then normalized so that the sum of the
eights for the entire sample was equal to the original
ample size. The descriptive statistics, measures of test
erformance, and p values presented should, therefore, be
epresentative of an unweighted sample from a similar
opulation.
ESULTS
etween July 1996 and March 1999, 5,582 apparently
ealthy men and women age 50 to 70 years underwent
lectron beam CT scanning of the coronary arteries. Of
hese, 28 subjects refused to stop taking cholesterol-
owering medicines or antioxidant vitamins and 161 were
ound to be ineligible (elevated cholesterol, ischemic
hanges on electrocardiogram, and so on). Of the remaining
,393 subjects, 1,005 were invited to participate in the
andomized clinical trial on the basis of a coronary calcium
core above the 80th percentile for age and gender. Subjects
ssigned to active treatment (n  490) were excluded,
eaving 4,903 in the natural history component of the study.
ollow-up was available at a mean of 4.3 years on 4,613 of
he original 4,903 study participants (94%).
Baseline characteristics of the study population are listed
n Table 1. Eighty-eight percent of study participants
escribed themselves as Caucasian. Subjects lost to
ollow-up were younger (57  7 years vs. 59  6 years, p 
.048) and had lower LDL cholesterol (129  34 mg/dl vs.
44  33 mg/dl, p  0.03), but were otherwise similar to
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July 5, 2005:158–65 Coronary Calcium and ASCVD Eventsor standard risk factors, calcium scores were similar among
hose with and without follow-up.
Atherosclerotic cardiovascular disease events occurred in
19 subjects (2.6%): nonfatal MI or coronary death in 40,
oronary revascularization (bypass surgery or percutaneous
ngioplasty) in 59, non-hemorrhagic stroke in 7, and
eripheral vascular surgery in 13. Of the 59 coronary
evascularization procedures, 42% were performed in sub-
ects hospitalized for unstable angina and 56% were per-
ormed after outpatient evaluation of recent onset chest
ain. Time from baseline scan to coronary revascularization
as 100 days in all of these cases, with a mean ( SD) of
.1  1.3 years. In just one case was a revascularization
rocedure performed on an asymptomatic subject.
Subjects with ASCVD events had higher baseline coro-
ary calcium scores (median [interquartile range]) than
hose without events: 384 (127, 800) versus 10 (0, 86) (p 
.0001).
escriptors of test performance. For each of the three
omposite end points of interest (all ASCVD events, all
AD events, and the sum of nonfatal MI and coronary
eath), event rates increased as a function of the baseline
alcium score (p  0.0001). Relative risks were similar for
ifferent end points. For example, for the 15% of study
articipants with calcium scores of 100 to 399 compared
ith the 33% of subjects with scores of 0, relative risk (95%
onfidence interval [CI]) ranged only from 10.2 for all
SCVD events (95% CI 5.1 to 20.1) and all coronary events
95% CI 4.8 to 21.7) to 10.4 (95% CI 3.4 to 32.3) for death
nd nonfatal MI. Relative risks were also similar for
eighted and unweighted analyses (Table 2). The sum of
ensitivity and specificity reached a maximum of 1.51 to
able 1. Baseline Characteristics of Study Population
ge (yrs)* 59  6
omen (%)* 35
otal cholestrol (mg/dl) 224  33
DL cholestrol (mg/dl) 143  33
DL cholestrol (mg/dl) 52  15
riglycerides (mg/dl) 141  104
ypertension (%) 34
iabetes (%) 6
urrent smokers (%) 10
amily history of premature CAD (%) 21
ody mass index 28  5
-reactive protein (mg/l) 1.84 (0.89, 3.96)
alcium score*
All 10 (0, 105)
Men 30 (1, 174)
Women 0.5 (0, 20)
n  4,613. For all other variables, n  1,293. Age, lipids, body mass index, and
oronary calcium score are presented as mean  SD. Because the distributions of
-reactive protein and calcium scores were skewed upward, results are presented as
he median value (interquartile range). Approximately seven percent of C-reactive
rotein values exceeded 10 mg/l. To convert cholesterol levels from mg/dl to mmol/l,
ivide by 38.7. To convert triglycerides from mg/dl to mmol/l, divide by 88.6. Body
ass index equals weight (kg) divided by height (m2).
CAD  coronary artery disease; HDL  high-density lipoprotein; LDL 
ow-density lipoprotein..55 at a calcium score threshold 100 (25% of the study
sopulation) for each of the three composite end points
Fig. 2).
Test performance was similar in the 1,357 subjects in
hom risk factors were measured. For example, for subjects
ith calcium scores 100 versus subjects with calcium
cores 100, relative risk was 13.0 (95% CI 5.7 to 29.6) for
ll ASCVD events, 14.5 (95% CI 5.8 to 36.0) for all CAD
vents, and 11.2 (95% CI 3.0 to 42.3) for nonfatal MI and
oronary death, compared with relative risks of 9.6 (95% CI
.7 to 13.9), 11.0 (95% CI 7.3 to 16.7), and 9.2 (95% CI 4.9
o 17.3), respectively, for all 4,613 participants.
oronary calcium, coronary disease risk factors, and
oronary disease events. In univariate correlation, most
tandard and conditional risk factors were associated with
RP and the coronary calcium score (Table 3). Exceptions
ere age and family history of premature coronary disease
or CRP and LDL cholesterol for the calcium score.
-reactive protein and the coronary calcium score were
eakly correlated (r  0.06, p  0.01).
In multivariate regression, the coronary calcium score was
trongly predicted (p  0.0001) by age, male gender, and
amily history of premature coronary disease. Associations
ith LDL cholesterol, current smoking, and hypertension
ecame or remained significant (0.01  p  0.001),
hereas associations with high-density lipoprotein (HDL)
holesterol (p  0.04) and diabetes mellitus (p  0.06) fell
o borderline levels. After adjustment for standard risk
actors, CRP levels no longer predicted the coronary cal-
ium score (p  0.22).
The calcium score predicted CAD events independently
f standard risk factors (chi-square 6.6, p 0.01) and the
ombination of standard risk factors and CRP (chi-square
6.6, p 0.01) (Table 4). In contrast, after adjustment for
tandard risk factors alone or together with baseline calcium
core, CRP did not predict CAD events (p  0.48).
The calcium score predicted CAD events more accurately
han the Framingham risk index (26); the area under the
OC curve was 0.79  0.03 for the calcium score versus
.68  0.03 for the Framingham index (p  0.0006).
onsistent with this difference, the calcium score also
nhanced risk stratification based on the Framingham index
p  0.0001 for trend; Fig. 3).
able 2. Coronary Calcium Score and All Coronary
isease Events*




–99 1,973 1.00 1.9 (0.8–4.2)
00–399 686 5.5 10.2 (4.8–21.6)
400 450 14.0 26.2 (12.6–53.7)
Includes coronary death, nonfatal myocardial infarction, coronary bypass surgery, and
ercutaneous coronary angioplasty (n  4,613). Relative risk is based on comparison
o subjects with calcium scores of zero. Analysis of unweighted sample yielded similar
esults, with relative risks of 1.0, 1.9, 10.3, and 26.9, respectively, for the different
trata of calcium scores.
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Coronary Calcium and ASCVD Events July 5, 2005:158–65hange in calcium score and subsequent coronary dis-
ase events. Median (interquartile range) increased by 4 (0,
8) U from baseline to the year two scan in subjects who did
ot sustain a coronary event at any time during the study. In
ontrast, median (interquartile range) increased by 247 (40,
71) U between the baseline and two-year examinations in
9 subjects who first experienced a CAD event after the year
wo scan (p  0.0001). (Subjects who experienced a CAD
vent in the first two years of the study were excluded from
his analysis because most received one or more metallic
tents, which cannot reliably be distinguished from coronary
alcification.)
In univariate analysis, baseline age, male gender, current
moking, hypertension, diabetes, family history of prema-
ure coronary disease, HDL cholesterol, body mass index,
nd triglycerides, but not LDL cholesterol (p  0.08) or
igure 2. Sensitivity (circles) and specificity (squares) for the prediction
alcium score (n  4,613).
able 3. Univariate Correlations: Standard Risk Factors,
-Reactive Protein, and Coronary Calcium Score (n  1,293)
C-Reactive
Protein Calcium Score
r p Value r p Value
ge 0.03 0.19 0.25 0.0001
ender (male) 0.07 0.003 0.33 0.0001
DL cholesterol 0.08 0.0006 0.03 0.15
DL cholestrol 0.21 0.0001 0.16 0.0001
ypertension 0.14 0.0001 0.18 0.0001
iabetes mellitus 0.09 0.0003 0.10 0.0001
urrent smoking 0.08 0.001 0.05 0.03
amily history 0.01 0.67 0.09 0.0001
riglycerides 0.22 0.0001 0.14 0.001
ody mass index 0.44 0.0001 0.16 0.0001
ystolic blood pressure 0.18 0.0001 0.21 0.0001
iastolic blood pressure 0.15 0.0001 0.15 0.0001
-reactive protein — — 0.06 0.01
alcium score 0.06 0.01 — —rbbreviations as in Table 1.urrent smoking (p  0.30), were all correlated (p  0.01)
ith change in calcium score. In multiple logistic regression,
nly age (p  0.03), male gender (p  0.04), LDL
holesterol (p  0.01), HDL cholesterol (p  0.04), and
wo-year change in calcium score (p  0.0001) were
ignificantly associated with subsequent CAD events. Two-
ear change in coronary calcium score was also highly
orrelated with baseline calcium score (r  0.92).
ISCUSSION
ith nearly 20,000 person-years of observation, this study
emonstrates that the electron beam CT scan-derived
oronary calcium score predicts ASCVD events, CAD
vents, and the composite of coronary death and nonfatal
I independently of and more accurately than standard
oronary risk factors. Although not sufficiently powerful to
egate the prognostic value of standard risk factors, the
alcium score enhanced risk stratification based on the
ramingham index (30), identifying intermediate-risk sub-
ects among those seemingly at low risk, low- and high-risk
ubjects among those apparently at intermediate risk, and
ntermediate-risk subjects among those classified as high
isk. In contrast, after adjustment for standard risk factors
nd the baseline calcium score, CRP did not predict events.
For the entire study population, relative risk ranged from
.2 to 11.1 for the composite end points of interest in
ubjects with calcium scores 100 (25% of the study
opulation) compared to subjects with calcium scores 100
the remaining 75% of the cohort). These relative risks are
pproximately five times higher than values typically re-
orted for standard (5,31) and newer (32) coronary risk
actors.
More likely than not, this study underestimated the true
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July 5, 2005:158–65 Coronary Calcium and ASCVD Eventsith high calcium scores were treated with aspirin, and only
bout 18% of subjects with low scores underwent physical
xamination, electrocardiography, or laboratory testing.
hus, the risk of ASCVD events was reduced by aspirin in
ubjects with high calcium scores (33,34), whereas the low
core group undoubtedly contained subjects who should
ave been excluded from a study of primary prevention
ecause of abnormalities on physical examination or elec-
rocardiogram. A slightly higher relative risk in the sub-
roup in which risk factors were measured and a complete
aseline examination was performed suggests that this was
o. For budgetary and logistical reasons, these examinations
ere not performed on the majority of low-score subjects.
his feature of study design also favored the null hypothesis.
Given the number, size, and methodologic integrity of
he studies that have established CRP as a risk factor for
oronary disease (32), the failure of CRP to predict events
ndependently of standard risk factors in the present study is
ost likely the result of sample size. Although the present
ndings do not invalidate CRP as a risk factor, they indicate
hat CRP, like standard risk factors, is not as powerful a
redictor of events as the calcium score. The relative risk of
RP, highest tertile versus lowest tertile, is 2 (32),
hereas the relative risk of a CAD event for the calcium
igure 3. Coronary event rates as a function of calcium score within the Fr




ender (male) 5.0 0.01
DL cholesterol 5.6 0.02
DL cholesterol 5.8 0.02
ypertension 3.0 0.08
iabetes mellitus 1.4 0.24
urrent smoking 1.3 0.25
amily history 1.0 0.33
-reactive protein — —
alcium score 6.6 0.01
-statistic 0.83
nalyses including CRP are based on all values measured. Exclusion of subjects with
rea under the receiver-operating characteristic curve (SAS PROC LOGISTIC [SA
CRP  C-reactive protein; other abbreviations as in Table 1.0 years; and high: 20% per year). There were no coronary events in the first
1,293).core, highest tertile versus lowest tertile, in the present
tudy was 13.9 (95% CI 7.1 to 27.3). Moreover, after
djustment for the calcium score, CRP failed to predict
vents (p  0.47). In the only other published direct
omparison of CRP and calcium score, after adjustment of
ach variable for the other, the association between the
alcium score and events remained robust (p  0.004),
hereas the association between CRP and events fell to
orderline levels (0.02  p  0.09; Park et al. [17]).
Less than 2% of age-eligible persons notified of this study
ventually enrolled. This low level of participation raises
uestions about the generalizability of the study results.
owever, with the exception a low prevalence of current
moking and a high prevalence of family history of prema-
ure CAD disease, neither of which had independent
rognostic significance, the prevalence of standard CAD
isk factors is similar to that reported in recent, large,
opulation-based studies (35–37). Although the area under
he ROC curve for the Framingham risk index is at the low
nd of values reported from recent, large, population-based
tudies, the c-statistics reported in Table 4 are well within
he range of previously reported values (38,39). Thus, it
eems unlikely that the study results are inapplicable to
symptomatic, middle-age Caucasians. On the other hand,
gham risk groups (low: 10% per 10 years; intermediate: 10% to 20% per
alcium Score, and All Coronary Disease Events (n  1,293)
ithout Calcium Score With CRP and Calcium Score
-Square p Value Chi-Square p Value
5.4 0.02 4.1 0.04
6.9 0.01 4.9 0.03
6.5 0.01 6.4 0.01
6.3 0.01 5.1 0.02
2.2 0.14 3.3 0.07
2.4 0.12 3.7 0.05
0.9 0.34 1.1 0.30
2.5 0.11 1.4 0.24
0.5 0.48 0.4 0.51
— — 6.6 0.01
0.80 0.85
10 mg/l reduced chi-square values to  0.42. The c-statistic is analogous to the
: Association of predicted probabilities and observed responses]).aminn, C
W
Chi
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Coronary Calcium and ASCVD Events July 5, 2005:158–65he number of ASCVD events in non-white study partici-
ants is not yet sufficient to support conclusions. This point
s important because African Americans appear to have less
oronary calcium than whites (40,41), and data in Native
mericans, whether English or Spanish speaking, or per-
ons of East Asian ancestry, are scant.
All five previous longitudinal studies of electron beam CT
canning have established that the coronary calcium score
redicts ASCVD events (13–18). However, due to meth-
dologic limitations, these same studies have failed to end
he debate over the incremental value of the coronary
alcium score relative to standard risk factors (11,12).
pecifically, because of concern about referral bias and/or
naccuracies in self-reported risk factors, the evidence pre-
ented in four positive, retrospective analyses of commercial
atabases has not been considered powerful enough to
verride the initially negative results from a prospective
tudy of a highly selected population, even though the
omogeneity of that population favored the null hypothesis
19).
The St. Francis Heart Study is unique in that it was both
rospective and population based. To date, it is also the
argest study of electron beam CT scanning for the early
etection of CAD. In middle-aged Caucasians, the results
f the St. Francis Heart Study speak for themselves: the
lectron beam CT-derived coronary calcium score predicted
SCVD events, including nonfatal MI and coronary death,
ndependently of and more accurately than standard coro-
ary risk factors. We eagerly await the results of the
ational Institutes of Health-sponsored Multiethnic Study
f Atherosclerosis (MESA), which is sufficiently powered to
ddress these issues in minorities.
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